Philadelphia, USA-based Medicus Pharma and Boston-based biotech Helix Nanotechnologies have entered into a non-binding ...

A Seoul-based biotech company, founded to develop innovative therapies for neurodegenerative and immune disorders.

Findings from the TRAILBLAZER-ALZ 2 long-term extension study highlight Kisunla (donanemab-azbt) continued to demonstrate ...

A clinical‑stage biotech company developing gene therapies to treat common joint diseases such as knee osteoarthritis, which ...